The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Influenza Drugs Market Research Report 2025

Global Influenza Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1980956

No of Pages : 105

Synopsis
The global Influenza Drugs market was valued at US$ 1707.6 million in 2023 and is anticipated to reach US$ 2151.5 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Influenza Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Drugs.
Report Scope
The Influenza Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Segment by Type
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
Segment by Application
Adults
Chidren
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Influenza Drugs Market Overview
1.1 Product Overview and Scope of Influenza Drugs
1.2 Influenza Drugs Segment by Type
1.2.1 Global Influenza Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Zanamivir
1.2.3 Oseltamivir Phosphate
1.2.4 Peramivir
1.2.5 Other Influenza Drugs
1.3 Influenza Drugs Segment by Application
1.3.1 Global Influenza Drugs Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Chidren
1.4 Global Influenza Drugs Market Size Estimates and Forecasts
1.4.1 Global Influenza Drugs Revenue 2019-2030
1.4.2 Global Influenza Drugs Sales 2019-2030
1.4.3 Global Influenza Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Influenza Drugs Market Competition by Manufacturers
2.1 Global Influenza Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Influenza Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Influenza Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Influenza Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Drugs, Product Type & Application
2.7 Influenza Drugs Market Competitive Situation and Trends
2.7.1 Influenza Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Influenza Drugs Players Market Share by Revenue
2.7.3 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Drugs Retrospective Market Scenario by Region
3.1 Global Influenza Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Influenza Drugs Global Influenza Drugs Sales by Region: 2019-2030
3.2.1 Global Influenza Drugs Sales by Region: 2019-2024
3.2.2 Global Influenza Drugs Sales by Region: 2025-2030
3.3 Global Influenza Drugs Global Influenza Drugs Revenue by Region: 2019-2030
3.3.1 Global Influenza Drugs Revenue by Region: 2019-2024
3.3.2 Global Influenza Drugs Revenue by Region: 2025-2030
3.4 North America Influenza Drugs Market Facts & Figures by Country
3.4.1 North America Influenza Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Influenza Drugs Sales by Country (2019-2030)
3.4.3 North America Influenza Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Influenza Drugs Market Facts & Figures by Country
3.5.1 Europe Influenza Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Influenza Drugs Sales by Country (2019-2030)
3.5.3 Europe Influenza Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Influenza Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Influenza Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Influenza Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Influenza Drugs Market Facts & Figures by Country
3.7.1 Latin America Influenza Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Influenza Drugs Sales by Country (2019-2030)
3.7.3 Latin America Influenza Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Influenza Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Influenza Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza Drugs Sales by Type (2019-2030)
4.1.1 Global Influenza Drugs Sales by Type (2019-2024)
4.1.2 Global Influenza Drugs Sales by Type (2025-2030)
4.1.3 Global Influenza Drugs Sales Market Share by Type (2019-2030)
4.2 Global Influenza Drugs Revenue by Type (2019-2030)
4.2.1 Global Influenza Drugs Revenue by Type (2019-2024)
4.2.2 Global Influenza Drugs Revenue by Type (2025-2030)
4.2.3 Global Influenza Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Influenza Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Influenza Drugs Sales by Application (2019-2030)
5.1.1 Global Influenza Drugs Sales by Application (2019-2024)
5.1.2 Global Influenza Drugs Sales by Application (2025-2030)
5.1.3 Global Influenza Drugs Sales Market Share by Application (2019-2030)
5.2 Global Influenza Drugs Revenue by Application (2019-2030)
5.2.1 Global Influenza Drugs Revenue by Application (2019-2024)
5.2.2 Global Influenza Drugs Revenue by Application (2025-2030)
5.2.3 Global Influenza Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Influenza Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb]
6.1.1 Bristol-Myers Squibb] Corporation Information
6.1.2 Bristol-Myers Squibb] Description and Business Overview
6.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb] Influenza Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb] Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Influenza Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Influenza Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Influenza Drugs Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Influenza Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Influenza Drugs Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Influenza Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Sanofi Pasteur
6.8.1 Sanofi Pasteur Corporation Information
6.8.2 Sanofi Pasteur Description and Business Overview
6.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Pasteur Influenza Drugs Product Portfolio
6.8.5 Sanofi Pasteur Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bayer Influenza Drugs Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Celgene
6.10.1 Celgene Corporation Information
6.10.2 Celgene Description and Business Overview
6.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Celgene Influenza Drugs Product Portfolio
6.10.5 Celgene Recent Developments/Updates
6.11 Seqirus
6.11.1 Seqirus Corporation Information
6.11.2 Seqirus Influenza Drugs Description and Business Overview
6.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Seqirus Influenza Drugs Product Portfolio
6.11.5 Seqirus Recent Developments/Updates
6.12 Protein Sciences Corporation
6.12.1 Protein Sciences Corporation Corporation Information
6.12.2 Protein Sciences Corporation Influenza Drugs Description and Business Overview
6.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Protein Sciences Corporation Influenza Drugs Product Portfolio
6.12.5 Protein Sciences Corporation Recent Developments/Updates
6.13 Serum Institute of India
6.13.1 Serum Institute of India Corporation Information
6.13.2 Serum Institute of India Influenza Drugs Description and Business Overview
6.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Serum Institute of India Influenza Drugs Product Portfolio
6.13.5 Serum Institute of India Recent Developments/Updates
6.14 Emergent Biosolutions
6.14.1 Emergent Biosolutions Corporation Information
6.14.2 Emergent Biosolutions Influenza Drugs Description and Business Overview
6.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Emergent Biosolutions Influenza Drugs Product Portfolio
6.14.5 Emergent Biosolutions Recent Developments/Updates
6.15 BioCryst Pharmaceuticals
6.15.1 BioCryst Pharmaceuticals Corporation Information
6.15.2 BioCryst Pharmaceuticals Influenza Drugs Description and Business Overview
6.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 BioCryst Pharmaceuticals Influenza Drugs Product Portfolio
6.15.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.16 Alvogen
6.16.1 Alvogen Corporation Information
6.16.2 Alvogen Influenza Drugs Description and Business Overview
6.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Alvogen Influenza Drugs Product Portfolio
6.16.5 Alvogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Drugs Industry Chain Analysis
7.2 Influenza Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Drugs Production Mode & Process
7.4 Influenza Drugs Sales and Marketing
7.4.1 Influenza Drugs Sales Channels
7.4.2 Influenza Drugs Distributors
7.5 Influenza Drugs Customers
8 Influenza Drugs Market Dynamics
8.1 Influenza Drugs Industry Trends
8.2 Influenza Drugs Market Drivers
8.3 Influenza Drugs Market Challenges
8.4 Influenza Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Influenza Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Influenza Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Influenza Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Influenza Drugs Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Influenza Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Influenza Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Influenza Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Influenza Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Influenza Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Influenza Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Influenza Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Influenza Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Influenza Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Influenza Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Influenza Drugs Sales by Region (2019-2024) & (K MT)
Table 18. Global Influenza Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Influenza Drugs Sales by Region (2025-2030) & (K MT)
Table 20. Global Influenza Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Influenza Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Influenza Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Influenza Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Influenza Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Influenza Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Influenza Drugs Sales by Country (2019-2024) & (K MT)
Table 27. North America Influenza Drugs Sales by Country (2025-2030) & (K MT)
Table 28. North America Influenza Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Influenza Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Influenza Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Influenza Drugs Sales by Country (2019-2024) & (K MT)
Table 32. Europe Influenza Drugs Sales by Country (2025-2030) & (K MT)
Table 33. Europe Influenza Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Influenza Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Influenza Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Influenza Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Influenza Drugs Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Influenza Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Influenza Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Influenza Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Influenza Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Influenza Drugs Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Influenza Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Influenza Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Influenza Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Influenza Drugs Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Influenza Drugs Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Influenza Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Influenza Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Influenza Drugs Sales (K MT) by Type (2019-2024)
Table 51. Global Influenza Drugs Sales (K MT) by Type (2025-2030)
Table 52. Global Influenza Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Influenza Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Influenza Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Influenza Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Influenza Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Influenza Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Influenza Drugs Price (USD/MT) by Type (2019-2024)
Table 59. Global Influenza Drugs Price (USD/MT) by Type (2025-2030)
Table 60. Global Influenza Drugs Sales (K MT) by Application (2019-2024)
Table 61. Global Influenza Drugs Sales (K MT) by Application (2025-2030)
Table 62. Global Influenza Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Influenza Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Influenza Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Influenza Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Influenza Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Influenza Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Influenza Drugs Price (USD/MT) by Application (2019-2024)
Table 69. Global Influenza Drugs Price (USD/MT) by Application (2025-2030)
Table 70. Bristol-Myers Squibb] Corporation Information
Table 71. Bristol-Myers Squibb] Description and Business Overview
Table 72. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Bristol-Myers Squibb] Influenza Drugs Product
Table 74. Bristol-Myers Squibb] Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. AstraZeneca Influenza Drugs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Eli Lilly Influenza Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Roche Influenza Drugs Product
Table 89. Roche Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKline Influenza Drugs Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Novartis Influenza Drugs Product
Table 99. Novartis Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Pfizer Influenza Drugs Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Sanofi Pasteur Corporation Information
Table 106. Sanofi Pasteur Description and Business Overview
Table 107. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Sanofi Pasteur Influenza Drugs Product
Table 109. Sanofi Pasteur Recent Developments/Updates
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Bayer Influenza Drugs Product
Table 114. Bayer Recent Developments/Updates
Table 115. Celgene Corporation Information
Table 116. Celgene Description and Business Overview
Table 117. Celgene Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Celgene Influenza Drugs Product
Table 119. Celgene Recent Developments/Updates
Table 120. Seqirus Corporation Information
Table 121. Seqirus Description and Business Overview
Table 122. Seqirus Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Seqirus Influenza Drugs Product
Table 124. Seqirus Recent Developments/Updates
Table 125. Protein Sciences Corporation Corporation Information
Table 126. Protein Sciences Corporation Description and Business Overview
Table 127. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Protein Sciences Corporation Influenza Drugs Product
Table 129. Protein Sciences Corporation Recent Developments/Updates
Table 130. Serum Institute of India Corporation Information
Table 131. Serum Institute of India Description and Business Overview
Table 132. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. Serum Institute of India Influenza Drugs Product
Table 134. Serum Institute of India Recent Developments/Updates
Table 135. Emergent Biosolutions Corporation Information
Table 136. Emergent Biosolutions Description and Business Overview
Table 137. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 138. Emergent Biosolutions Influenza Drugs Product
Table 139. Emergent Biosolutions Recent Developments/Updates
Table 140. BioCryst Pharmaceuticals Corporation Information
Table 141. BioCryst Pharmaceuticals Description and Business Overview
Table 142. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 143. BioCryst Pharmaceuticals Influenza Drugs Product
Table 144. BioCryst Pharmaceuticals Recent Developments/Updates
Table 145. Alvogen Corporation Information
Table 146. Alvogen Description and Business Overview
Table 147. Alvogen Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 148. Alvogen Influenza Drugs Product
Table 149. Alvogen Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Influenza Drugs Distributors List
Table 153. Influenza Drugs Customers List
Table 154. Influenza Drugs Market Trends
Table 155. Influenza Drugs Market Drivers
Table 156. Influenza Drugs Market Challenges
Table 157. Influenza Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Drugs
Figure 2. Global Influenza Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Influenza Drugs Market Share by Type in 2023 & 2030
Figure 4. Zanamivir Product Picture
Figure 5. Oseltamivir Phosphate Product Picture
Figure 6. Peramivir Product Picture
Figure 7. Other Influenza Drugs Product Picture
Figure 8. Global Influenza Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Influenza Drugs Market Share by Application in 2023 & 2030
Figure 10. Adults
Figure 11. Chidren
Figure 12. Global Influenza Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Influenza Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Influenza Drugs Sales (2019-2030) & (K MT)
Figure 15. Global Influenza Drugs Average Price (USD/MT) & (2019-2030)
Figure 16. Influenza Drugs Report Years Considered
Figure 17. Influenza Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Influenza Drugs Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Influenza Drugs Players: Market Share by Revenue in 2023
Figure 20. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Influenza Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Influenza Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Influenza Drugs Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Influenza Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Influenza Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Influenza Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Influenza Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Influenza Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Influenza Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Influenza Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Influenza Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Influenza Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Influenza Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Influenza Drugs by Type (2019-2030)
Figure 57. Global Influenza Drugs Price (USD/MT) by Type (2019-2030)
Figure 58. Global Sales Market Share of Influenza Drugs by Application (2019-2030)
Figure 59. Global Revenue Market Share of Influenza Drugs by Application (2019-2030)
Figure 60. Global Influenza Drugs Price (USD/MT) by Application (2019-2030)
Figure 61. Influenza Drugs Value Chain
Figure 62. Influenza Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’